|
1 Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr, 1971, 78(1): 180－181.
|
|
2 Arnold CJ, Miller GG, Zello GA. Parenteral nutrition associated cholestasis in infants with intestinal failure. FASEB J, 2002, 16: A281.
|
|
3 Carter BA, Shulman RJ. Mechanisms of disease: Update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol, 2007, 4(5): 277－287.
|
|
4 Emerick KM, Whitington PF. Molecular basis of neonatal cholestasis. Pediatr Clin North Am, 2002, 49(1): 221－235.
|
|
5 Zollner G, Marschall HU, Waqnerm D, et al. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations. Mol Pharm, 2006, 3(3): 231－251.
|
|
6 Georgeson KE. The prevention and treatment of parenteral nutrition－associated jaundice in infants and children. Transplant Proc, 2002, 34(3): 898－899.
|
|
7 Robinson DT, Ehrenkranz RA. Parenteral nutrition－associated cholestasis in small for gestational age infants. J Pediatr, 2008, 152(1): 59－62.
|
|
8 Shamir R, Maayan－Metzger A, Bujanover Y, et al. Liver enzyme abnormalities in gram－negative bacteremia of premature infants. Pediatr Infect Dis J, 2000, 19(6): 495－498.
|
|
9 Lucas A, Bloom SR, Aynsley－Green A, et al. Metabolic and endocrine consequences of depriving preterm infants of enteral nutrition. Acta Paediatr Scand，1983, 72(2): 245－249.
|
|
10 Lloyd DA, Gabe SM. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc, 2007, 66(4): 530－538.
|
|
11 Xie G, Li YJ. Hepatic injury from long－term use of total parenteral nutrition. Adverse Drug Reactions J, 2007，9(5)：335－338.[谢钢，李运景. 全胃肠外营养长期应用引起的肝损害．药物不良反应杂志，2007, 9(5): 335－338.]
|
|
12 Kaufman SS, Condolesi GE, Fishbein TM. Parenteral nutrition associated liver disease. Semi Neonatol, 2003, 8(5): 375－381.
|
|
13 Spencer AU, Yu S, Tracy TF, et al. Parenteral nutrition－associated cholestasis in neonates: Multivariate analysis of the potential protective effect of taurine. J Parenter Enteral Nutr, 2005, 29(5)：337－343.
|
|
14 Arnold CJ, Miller GG, Zello GA. Parenteral nutrition－associated cholestasis in neonates: The role of aluminum. Nutr Rev, 2003, 61(9)：306－310.
|
|
15 Iyer KR, Spit ZL, Clayton P. New insight into mechanisms of parenteral associated cholestasis, role of plant sterols. J Pediatr Surg, 1998, 33(1): 1－6.
|
|
16 Cruccetti A, Pierro A, Uronen H, et al. Surgical infants on total parenteral nutrition have impaired cytokine responses to microbial challenge. J Pediatr Surg, 2003, 38(1): 138－142.
|
|
17 Forrest EH, Uien KA, Dickson S, et al. Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumor necrosis factor alpha. Liver, 2002, 22(4): 317－320.
|
|
18 Ghose R, Zimmerman TL, Thevananther S, et al. Endotoxin leads to rapid subcellular re－localization of hepatic RXR alpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept, 2004, 2(1): 4.
|
|
19 Loff S, Kranzkub B, Moghadam M, et al. Parenteral nutrition－induced hepatobiliary dysfunction in infants and prepubertal rabbits. Pediatr Surg Int, 1999, 15(7): 479－482.
|
|
20 Kelly DA. Liver complications of pediatric parenteral nutrition－epidemiology. Nutrition, 1998, 14(1)：153－157.
|
|
21 Albers MJ, de Gast－Bakker DA, van Dam NA, et al. Male Sex predisposes the newborn surgical patient to parenteral nutrition－associated cholestasis and to sepsis. Arch Surg, 2002, 137(7): 789－793.
|
|
22 Mullick FG, Moran CA, Ishak KG. Total parenteral nutrition: A histopathologic analysis of the liver changes in 20 children. Mod Pathol, 1994, 7(2): 190－194.
|
|
23 Hwang TL, Lue MC, Chen LL. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology, 2000, 47(35): 1347－1350.
|
|
24 Wallis K, Lloyd DA, Gabe SM. Promoting intestinal adaptation. Br J Hosp Med(Lond), 2007, 68(1)：11－14.
|
|
25 Shin JI, Namgung R, Park MS, et al. Could lipid infusion be a risk for parenteral nutrition－associated cholestasis in low birth weight neonates? Eur J Pediatr, 2008, 167(2)：197－202.
|
|
26 Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol, 2006, 3(6): 318－328.
|
|
27 Chen CY, Tsao PN, Chen HL, et al. Ursodeoxycholic acid (UDCA) therapy in very－low－birth－weight infants with parenteral nutrition－associated cholestasis. J Pediatr, 2004, 145(3): 317－321.
|
|
28 Daniel HT, Thomas FT, Moustafa MA, et al. Use of cholecystokinin－octapeptide for the prevention of parenteral nutrition－associated cholestasis. Pediatrics, 2005, 115(5)：1332－1340.
|